Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacology of Methamphetamine Isomers in Healthy Volunteers
NCT06746831Phase 1Not yet recruiting
- Sponsor
- University of Wisconsin–Madison
- Start
- Jan 2027
- Primary completion
- Jan 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of methamphetamine (3 arms), sponsored by University of Wisconsin–Madison. Primary endpoints: Peak concentration and Area under the concentration versus time curve. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
methamphetamine
Beyond the preview
Go deeper on NCT06746831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06746831.